Featured Research

from universities, journals, and other organizations

University Of Illinois At Chicago Chemists Synthesize Potent Anticancer Compound

Date:
November 10, 2000
Source:
University Of Illinois At Chicago
Summary:
An intricate molecule with exciting anticancer properties that is found only in minute amounts in a few species of South Pacific sponges has for the first time been synthesized in the laboratory by University of Illinois at Chicago chemists.

An intricate molecule with exciting anticancer properties that is found only in minute amounts in a few species of South Pacific sponges has for the first time been synthesized in the laboratory by UIC chemists. The 50-step, atom-by-atom assembly, reported in the Nov. 8 issue of the Journal of the American Chemical Society, not only means that scientists will have greater quantities of the rare molecule to study but also points the way to the synthesis of variants that may be even more medicinally useful.

The compound, laulimalide, named from the Hawaiian word laulima, "to work together," attacks cancer cells in a manner similar to the successful cancer drug Taxol but appears to be far more potent against tumors that have developed multiple-drug resistance. Discovered more than 10 years ago, laulimalide, which is chemically unrelated to Taxol, has been studied in several laboratories but is hard to come by, amounting to only one-tenth of 1 percent of a sponge's weight. It has also proven very difficult to make in the lab.

"The molecule is a most challenging one in its structural complexity," says Arun Ghosh, professor of chemistry at UIC. He and graduate student Yong Wang were racing as many as 10 top teams worldwide to synthesize the molecule, whose structure contains a 20-membered ring and nine asymmetric carbon atoms whose "handedness," or stereochemistry must be maintained.

"Building a molecule in a flask with all the bonds and specific configurations found in nature is as hard as building a space shuttle," Ghosh said. "We needed to preserve the stereochemistry at nine centers, maintain the cis configuration of six olefin bonds, and protect the epoxide and ester functions of the molecule."

Most exciting, Ghosh said, is that the stepwise synthesis allows for total control of the handedness of each of the nine asymmetric centers. "We now have the ability to invert each of them, and test each of those molecules for enhanced antitumor activity," he said, making a total of 512 possible variants.

Both Taxol and laulimalide work by disrupting the function of the cellular microtubules required for cell division, but laulimalide also inhibits the P-glycoprotein that is responsible for multiple-drug resistance in those tumor cells that possess it. Although laulimalide is only one-fifth as potent as Taxol in drug-sensitive laboratory cell lines, it is as much as 100 times more potent than Taxol in multi-drug-resistant cell lines.

The research reported in JACS was funded by the National Institute of General Medical Sciences, one of the National Institutes of Health.


Story Source:

The above story is based on materials provided by University Of Illinois At Chicago. Note: Materials may be edited for content and length.


Cite This Page:

University Of Illinois At Chicago. "University Of Illinois At Chicago Chemists Synthesize Potent Anticancer Compound." ScienceDaily. ScienceDaily, 10 November 2000. <www.sciencedaily.com/releases/2000/11/001110072735.htm>.
University Of Illinois At Chicago. (2000, November 10). University Of Illinois At Chicago Chemists Synthesize Potent Anticancer Compound. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2000/11/001110072735.htm
University Of Illinois At Chicago. "University Of Illinois At Chicago Chemists Synthesize Potent Anticancer Compound." ScienceDaily. www.sciencedaily.com/releases/2000/11/001110072735.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Poses Little Threat To U.S.: CDC

Ebola Outbreak Poses Little Threat To U.S.: CDC

Newsy (July 29, 2014) The Ebola outbreak in West Africa poses little threat to Americans, according to officials with the Centers for Disease Control and Prevention. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins